HoldsUp

Dale Bredesen

Dale Bredesen is a researcher whose work focuses on cognitive decline and Alzheimer's disease. His published research investigates precision medicine and multi-factorial interventions, including dietary protocols such as the KetoFLEX 12/3 diet and personalized therapeutic programs. Additionally, his studies explore molecular mechanisms, metabolic pathways, and targeted pharmacological agents for Alzheimer's disease.

31 claims checked on air: 3 context 1 contradicted 4 overstated 19 supported 4 unverified

What they said on air - contradicted

2 citing their own research

0:47:15contradictedlowHow to Make Your Brain Ageless: Prevent Cognitive Decline &

A study found an association between high levels of Akkermansia muciniphila in the gut and amyotrophic lateral sclerosis (ALS).

"There was one study that suggested that high Akkermansia was associated with ALS." (said at 0:47:15)

Published evidence on the gut microbiome in amyotrophic lateral sclerosis (ALS) demonstrates the inverse relationship: Akkermansia muciniphila is depleted in patients with ALS and has been shown to be protective, not associated with disease promotion or elevated levels. A landmark 2019 study in Nature showed that Akkermansia muciniphila ameliorated ALS symptoms and extended survival in transgenic ALS mouse models via nicotinamide production, while human ALS cohorts exhibited reduced abundance of beneficial commensals like Akkermansia. Although elevated Akkermansia has been reported in other neurodegenerative conditions (such as Parkinson's disease and multiple sclerosis), published ALS studies identify low, not high, Akkermansia abundance.

Fact-checked episodes

Publications